Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   DOLORES LOPEZ-TERRADA   and   ANDREA MARCOGLIESE.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.297
         
        
        
     
 
    
        
        - 
            Co-Occurrence of ETV6::RUNX1 and P2RY8::CRLF2 Fusion in a Patient with Relapsed Acute B Lymphoblastic Leukemia. Ann Clin Lab Sci. 2025 Jan; 55(1):133-141.
            
            
                Score: 0.059
            
         
        
        - 
            Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Jul-Aug; 27(4):348-353.
            
            
                Score: 0.056
            
         
        
        - 
            Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression. Leuk Lymphoma. 2023 02; 64(2):462-467.
            
            
                Score: 0.051
            
         
        
        - 
            Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. Haematologica. 2022 08 01; 107(8):1880-1890.
            
            
                Score: 0.050
            
         
        
        - 
            Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis. Pediatr Hematol Oncol. 2020 Feb; 37(1):76-89.
            
            
                Score: 0.041
            
         
        
        - 
            Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2019 10; 66(10):e27905.
            
            
                Score: 0.040